<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="at the end of 2019, the National Health Commission of" exact="China" post="released more details about the epidemic in early 2020"/>
 <result pre="thought that the Hunan seafood market in Wuhan city in" exact="China" post="was the origin of the outbreak. Although it had"/>
 <result pre="Although it had been proposed that the COVID-19 patients in" exact="China" post="might have utilized infected animals as a foodstuff, or"/>
 <result pre="recent investigations have suggested that pangolins that were smuggled from" exact="Malaysia" post="to China, along with other possible intermediate hosts like"/>
 <result pre="five percent among tens of thousands of confirmed patients in" exact="China" post="[30]. The spread of SARS-CoV-2 from asymptomatic individuals (or"/>
 <result pre="SARS-CoV-2 had not been able to spread quickly in southern" exact="China" post="[49]. Although the above-mentioned reports suggest a relationship between"/>
 <result pre="A study in six departments of a hospital in Wuhan," exact="China" post="demonstrated that the use of N95 masks, disinfectants, and"/>
 <result pre="trials Identifier Status country Tocilizumab inÂ COVID-19Â Pneumonia NCT04317092 Recruiting" exact="Italy" post="Evaluation of the Efficacy and Safety of Sarilumab in"/>
 <result pre="Safety of Sarilumab in Hospitalized Patients WithÂ COVID-19 NCT04315298 Recruiting" exact="United States" post="A Pilot Study of Sildenafil inÂ COVID-19 NCT04304313 Recruiting"/>
 <result pre="States A Pilot Study of Sildenafil inÂ COVID-19 NCT04304313 Recruiting" exact="China" post="ACE Inhibitors, Angiotensin II Type-I Receptor Blockers, and Severity"/>
 <result pre="Blockers, and Severity of COVID-19 (CODIV-ACE) NCT04318418 Not yet recruiting" exact="Italy" post="Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as"/>
 <result pre="Cases and Chemoprophylaxis of Contacts as Prevention (HCQ4COV19) NCT04304053 Recruiting" exact="Spain" post="The Use PUL-042 Inhalation Solution to Prevent COVID-19 in"/>
 <result pre="Sarilumab Trial - CORIMUNO-19 - SARI NCT04324073 Not yet recruiting" exact="France" post="Hydroxychloroquine Versus Placebo in Patients Presenting COVID-19 Infection and"/>
 <result pre="of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 NCT04323527 Recruiting" exact="Brazil" post="Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for"/>
 <result pre="2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection NCT04283461 Recruiting" exact="United States" post="Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) NCT04322682 Recruiting Canada Tocilizumab"/>
 <result pre="Recruiting United States Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) NCT04322682 Recruiting" exact="Canada" post="Tocilizumab for SARS-CoV2 Severe Pneumonitis NCT04315480 Not yet recruiting"/>
 <result pre="Canada Tocilizumab for SARS-CoV2 Severe Pneumonitis NCT04315480 Not yet recruiting" exact="Italy" post="Efficacy and Safety of Darunavir and Cobicistat for Treatment"/>
 <result pre="Cobicistat for Treatment of Pneumonia Caused by 2019-nCoV NCT04252274 Recruiting" exact="China" post="Treatment and Prevention of Traditional Chinese Medicines (TCMs) on"/>
 <result pre="of Traditional Chinese Medicines (TCMs) on 2019-nCoV Infection NCT04251871 Recruiting" exact="China" post="COVIDL1: A Study to Investigate the Efficacy of Tradipitant"/>
 <result pre="Inhalation in Severe Acute Respiratory Syndrome in COVID-19 NCT04306393 Recruiting" exact="United States" post="Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult"/>
 <result pre="Bacterial and Viral Lung (COVID-19) Infections NCT03331445 Active, not recruiting" exact="Canada" post="NK Cells Treatment for Novel Coronavirus Pneumonia NCT04280224 Recruiting"/>
 <result pre="Canada NK Cells Treatment for Novel Coronavirus Pneumonia NCT04280224 Recruiting" exact="China" post="Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir"/>
 <result pre="recruiting Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 NCT04308668 Recruiting" exact="United States" post="STOP PIV - Phase III DAS181 Lower Tract PIV"/>
 <result pre="DAS181 Lower Tract PIV Infection in Immunocompromised Subjects NCT03808922 Recruiting" exact="United States" post="Norwegian Coronavirus Disease 2019 Study NCT04316377 Not yet recruiting"/>
 <result pre="yet recruiting Lessening Organ Dysfunction With VITamin C NCT03680274 Recruiting" exact="Canada" post="Glucocorticoid Therapy for Novel CoronavirusCritically Ill Patients With Severe"/>
 <result pre="CoronavirusCritically Ill Patients With Severe Acute Respiratory Failure NCT04244591 Recruiting" exact="China" post="Convalescent Plasma to Limit Coronavirus Associated Complications NCT04325672 Not"/>
 <result pre="Plasma to Limit Coronavirus Associated Complications NCT04325672 Not yet recruiting" exact="United States" post="Vitamin C Infusion for the Treatment of Severe 2019-nCoV"/>
 <result pre="for the Treatment of Severe 2019-nCoV Infected Pneumonia NCT04264533 Recruiting" exact="China" post="Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory"/>
 <result pre="RoActemra iv, RoActemra sc, Kevzara sc NCT04322773 Not yet recruiting" exact="Denmark" post="Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in"/>
 <result pre="Associated With Azythromycin in SARS-Cov-2 Virus NCT04322123 Not yet recruiting" exact="Brazil" post="Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild"/>
 <result pre="(GS-5734â&quot;¢) in Participants With Severe Coronavirus Disease (COVID-19) NCT04292899 Recruiting" exact="United States" post="NestCellÂ® Mesenchymal Stem Cell to Treat Patients With Severe"/>
 <result pre="or Critically Severe Patients With COVID-19 Pneumonia-RCT (BEST-RCT) NCT04305106 Recruiting" exact="China" post="The Efficacy and Safety of Thalidomide in the Adjuvant"/>
 <result pre="of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells NCT04313322 Recruiting" exact="Jordan" post="Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)"/>
 <result pre="in the Treatment of COVID-19 (TT-NPC) NCT04308317 Enrolling by invitation" exact="China" post="Fingolimod in COVID-19 NCT04280588 Recruiting China CD24Fc as a"/>
 <result pre="NCT04308317 Enrolling by invitation China Fingolimod in COVID-19 NCT04280588 Recruiting" exact="China" post="CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment (SAC-COVID)v"/>
 <result pre="Non-antiviral Immunomodulator in COVID-19 Treatment (SAC-COVID)v NCT04317040 Not yet recruiting" exact="United States" post="Treatment With Mesenchymal Stem Cells for Severe Corona Virus"/>
 <result pre="Stem Cells for Severe Corona Virus Disease 2019(COVID-19) NCT04288102 Recruiting" exact="China" post="The Clinical Study of Carrimycin on Treatment Patients With"/>
 <result pre="recruiting Efficacy and Safety of Corticosteroids in COVID-19(Methylprednisolone) NCT04273321 Recruiting" exact="China" post="Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) NCT04318444"/>
 <result pre="Exposure Prophylaxis for Coronavirus Disease (COVID-19) NCT04318444 Not yet recruiting" exact="United States" post="Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19"/>
 <result pre="recruiting Safety and Immunity of Covid-19 aAPC Vaccine NCT04299724 Recruiting" exact="China" post="Immunity and Safety of Covid-19 Synthetic Minigene Vaccine NCT04276896"/>
 <result pre="Immunity and Safety of Covid-19 Synthetic Minigene Vaccine NCT04276896 Recruiting" exact="China" post="A Phase I Clinical Trial in 18â€&quot;60 Adults (APICTH)(vaccine)"/>
 <result pre="Phase I Clinical Trial in 18â€&quot;60 Adults (APICTH)(vaccine) NCT04313127 Recruiting" exact="China" post="Favipiravir Combined With Tocilizumab in the Treatment of Corona"/>
 <result pre="in the Treatment of Corona Virus Disease 2019 NCT04310228 Recruiting" exact="China" post="Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp"/>
 <result pre="and Mild Novel Coronavirus Pneumonia (COVID-19) NCT04273763 Enrolling by invitation" exact="China" post="Yinhu Qingwen Decoction for the Treatment of Mild /"/>
 <result pre="Treatment of Mild / Common CoVID-19 NCT04278963 Active, not recruiting" exact="China" post="Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Chloroquine"/>
 <result pre="COVID19: A Randomized Control Trial (THDMS-COVID19) NCT04303299 Not yet recruiting" exact="Thailand" post="The Effect of T89 on Improving Oxygen Saturation and"/>
 <result pre="of Cytokine Release Syndrome (CRS) in COVID-19 (TACOS) NCT04306705 Recruiting" exact="China" post="Mild/Moderate 2019-nCoV Remdesivir RCT NCT04252664 Recruiting China Losartan for"/>
 <result pre="(TACOS) NCT04306705 Recruiting China Mild/Moderate 2019-nCoV Remdesivir RCT NCT04252664 Recruiting" exact="China" post="Losartan for Patients With COVID-19 Requiring Hospitalization NCT04312009 Not"/>
 <result pre="for Patients With COVID-19 Requiring Hospitalization NCT04312009 Not yet recruiting" exact="United States" post="Trial of Treatments for COVID-19 in Hospitalized Adults (DisCoVeRy)Drug:"/>
 <result pre="Patients With COVID-19 Not Requiring Hospitalization NCT04311177 Not yet recruiting" exact="United States" post="Study of Human Umbilical Cord Mesenchymal Stem Cells in"/>
 <result pre="Treatment of Novel Coronavirus Severe Pneumonia NCT04273646 Not yet recruiting" exact="China" post="Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With"/>
 <result pre="for Pneumonia Patients Infected With 2019 Novel Coronavirus NCT04252118 Recruiting" exact="China" post="The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV"/>
 <result pre="in the 2019-nCoV PneumoniaDrug: Abidol hydrochloride, Oseltamivir, Lopinavir/ritonavir NCT04255017 recruiting" exact="China" post="A Prospective/Retrospective, Randomized Controlled Clinical Study of Interferon Atomization"/>
 <result pre="Abidol hydrochloride, Abidol Hydrochloride combined with Interferon atomization NCT04254874 recruiting" exact="China" post="Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia"/>
 <result pre="Severe or Critical Patients With COVID-19 Pneumonia (BEST-CP) NCT04275414 recruiting" exact="China" post="A Randomized, Open, Controlled Clinical Study to Evaluate the"/>
 <result pre="Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia NCT04261270 recruiting" exact="China" post="Intravenous Aviptadil for COVID-19 Associated Acute Respiratory Distress (COVID-AIV)"/>
 <result pre="COVID-19 Associated Acute Respiratory Distress (COVID-AIV) NCT04311697 Not yet recruiting" exact="Israel" post="The Efficacy of Different Hormone Doses in 2019-nCoV Severe"/>
 <result pre="Different Hormone Doses in 2019-nCoV Severe PneumoniaDrug: Methylprednisolone NCT04263402 recruiting" exact="China" post="Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (NoCovid)"/>
 <result pre="Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (NoCovid) NCT04305457 Recruiting" exact="United States" post="Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label,"/>
 <result pre="Infected by COVID-19: an Open-label, Pilot Study. (BARI-COVID) NCT04320277 Recruiting" exact="Italy" post="Adaptive COVID-19 Treatment Trial (ACTT)Drug: Remdesivir NCT04280705 Recruiting United"/>
 <result pre="Recruiting Italy Adaptive COVID-19 Treatment Trial (ACTT)Drug: Remdesivir NCT04280705 Recruiting" exact="United States" post="Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With"/>
 <result pre="N-acetylcysteineÂ +Â Fuzheng Huayu Tablet, N-acetylcysteineÂ +Â Placebo NCT04279197 Recruiting" exact="China" post="NO Prevention of COVID-19 for Healthcare ProvidersDrug: Inhaled nitric"/>
 <result pre="PatientsDrug: Immunoglobulin of cured patients, Î³-Globulin NCT04264858 Not yet recruiting" exact="China" post="Efficacy and Safety of IFN-Î±2Î² in the Treatment of"/>
 <result pre="StaffDrug: recombinant human Interferon Alpha-1b, thymosin alpha 1 NCT04320238 Recruiting" exact="China" post="Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19"/>
 <result pre="Inactivated Convalescent Plasma in the Treatment of COVID-19 NCT04292340 Recruiting" exact="China" post="Clinical Study of Arbidol Hydrochloride Tablets in the Treatment"/>
 <result pre="of Novel Coronavirus InfectionDrug: GanovoÂ +Â ritonavir+/-Interferon nebulization NCT04291729 Completed" exact="China" post="Eculizumab (Soliris) in Covid-19 Infected Patients NCT04288713 Available Severe"/>
 <result pre="Infected Patients NCT04288713 Available Severe 2019-nCoV Remdesivir RCT NCT04257656 Recruiting" exact="China" post="nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome"/>
 <result pre="Inhalation in Severe Acute Respiratory Syndrome in COVID-19 NCT04306393 Recruiting" exact="United States" post="Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel"/>
 <result pre="Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(CoV) Pneumonia NCT04269525 Recruiting" exact="China" post="Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir"/>
 <result pre="for the Treatment of Severe 2019-nCoV Infected Pneumonia NCT04264533 Recruiting" exact="China" post="Expanded Access Remdesivir (RDV; GS-5734â&quot;¢) NCT04302766 Available Xiyanping Injection"/>
 <result pre="of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection NCT04283461 recruiting" exact="United States" post="Tocilizumab for SARS-CoV2 Severe Pneumonitis NCT04315480 Not yet recruiting"/>
 <result pre="States Tocilizumab for SARS-CoV2 Severe Pneumonitis NCT04315480 Not yet recruiting" exact="Italy" post="Efficacy and Safety of Darunavir and Cobicistat for Treatment"/>
 <result pre="Cobicistat for Treatment of Pneumonia Caused by 2019-nCoV NCT04252274 recruiting" exact="China" post="Efficacy and Safety of Hydroxychloroquine for Treatment of Pneumonia"/>
 <result pre="for Treatment of Pneumonia Caused by 2019-nCoV (HC-nCoV) NCT04261517 Completed" exact="China" post="Treatment and Prevention of Traditional Chinese Medicines (TCMs) on"/>
 <result pre="therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) NCT04251871 recruiting" exact="China" post="Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to"/>
 <result pre="Meplazumab for Injection to Treat With 2019-nCoV Pneumonia NCT04275245 recruiting" exact="China" post="Stem Cell Educator Therapy Treat the Viral Inflammation Caused"/>
 <result pre="recruiting NK Cells Treatment for Novel Coronavirus Pneumonia NCT04280224 Recruiting" exact="China" post="Glucocorticoid Therapy for Novel CoronavirusCritically Ill Patients With Severe"/>
 <result pre="Patients With Severe Acute Respiratory FailureDrug: methylprednisolone therapy NCT04244591 Recruiting" exact="China" post="Norwegian Coronavirus Disease 2019 StudyDrug: Hydroxychloroquine Sulfate NCT04316377 Not"/>
 <result pre="Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment NCT04276688 Recruiting" exact="China" post="Post-exposure Prophylaxis for SARS-Coronavirus-2 Drug: Hydroxychloroquine NCT04308668 Recruiting United"/>
 <result pre="Recruiting China Post-exposure Prophylaxis for SARS-Coronavirus-2 Drug: Hydroxychloroquine NCT04308668 Recruiting" exact="United States" post="A Pilot Clinical Study on Inhalation of Mesenchymal Stem"/>
 <result pre="(2019-nCoV), December 2019 to January 2020. Eurosurveillance. 2020;25(4). 5Parry J." exact="China" post="coronavirus: cases surge as official admits human to human"/>
 <result pre="domesticated animals to SARSâ€&quot;coronavirus 2Science2020 46STRAITSTIMES T. Second dog in" exact="Hong Kong" post="tests positive for coronavirus 2020 MAR 20 [Available from:"/>
 <result pre="for severe acute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospitalJ. Antimicrob. Chemother.565200591992216183666 138Mair-JenkinsJ.Saavedra-CamposM.BaillieJ.K.ClearyP.KhawF.-M.LimW.S.The effectiveness of convalescent plasma and"/>
 <result pre="al. Use of convalescent plasma therapy in SARS patients in" exact="Hong Kong." post="European Journal of Clinical Microbiology and Infectious Diseases. 2005;24(1):44-6."/>
</results>
